L. JARA PALOMARES (Sevilla, Spain), F. Couturaud (Brest, France)
Introduction
L. JARA PALOMARES (Sevilla, Spain), F. Couturaud (Brest, France)
|  |
Diagnostic and prognostic value of pentraxin-3 in pulmonary thromboembolism
R. Bayler (Ankara, Turkey), S. Sarinc Ulasli (Ankara, Turkey), A. Batur (Ankara, Turkey), F. Tekin (Van, Turkey), G. Durhan (Ankara, Turkey), Z. Dikmen (Ankara, Turkey), S. Karahan (Ankara, Turkey), Y. Sener (Ankara, Turkey), A. Aksan (Hakkari, Turkey), M. Yilmaz (Ankara, Turkey), E. Babaoglu (Ankara, Turkey), E. Kaya (Ankara, Turkey), D. Koksal (Ankara, Turkey)
|  |
Right heart strain assessment on CTPA following acute pulmonary embolism: interobserver variability between radiologists and thoracic physicians
C. Samaranayake (Brisbane, Australia), M. Craigie (Brisbane, Australia), P. Bell (Brisbane, Australia), C. Mccabe (London, United Kingdom), J. Upham (Brisbane, Australia), J. Coucher (Brisbane, Australia), G. Keir (Brisbane, Australia)
|   |
Baseline characteristics and Outcomes in Patients with Venous Thromboembolism and Active Lung Cancer – a Nationwide Cohort Study in France
L. Bertoletti (Saint Etienne Cedex, France), G. Gusto (Paris, France), A. Khachatryan (London, United Kingdom), N. Quignot (Paris, France), J. Chaves (Madrid, Spain), A. Moniot (Paris, France), R. Mokgokong (London, United Kingdom), I. Mahé (Paris, France)
| |
Cancer Associated Thrombosis:how many lung cancer patients seen in clinical practice would be eligible to a DOAC randomized controlled trial?
B. Petit (Saint Etienne, France), V. Mismetti (Saint Etienne, France), S. Soudet (Amiens, France), G. Poenou (Paris, France), E. Zarrat (Amiens, France), T. Machuron (Saint-Etienne, France), S. Acassat (Saint-Etienne, France), L. Plaisance (Paris, France), H. Helfer (Paris, France), C. Le Hello (Saint-Etienne, France), M. Sevestre (Amiens, France), I. Mahé (Paris, France), L. Bertoletti (Saint-Etienne, France)
| |
Catheter-directed therapies in chronic thromboembolic pulmonary hypertension
J. Yang (La Jolla, United States), N. Kim (La Jolla, United States), S. Kligerman (La Jolla, United States), T. Fernandes (La Jolla, United States), D. Papamatheakis (La Jolla, United States), D. Poch (La Jolla, United States), M. Madani (La Jolla, United States), V. Pretorius (La Jolla, United States), K. Kerr (La Jolla, United States)
| |
Efficacy and safety of balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension comorbid to chronic obstructive pulmonary disease
H. Fujii (Kobe, Japan), Y. Taniguchi (Kobe, Japan), S. Yoneda (Kobe, Japan), K. Miwa (Kobe, Japan), K. Yanaka (Kobe, Japan), N. Emoto (Kobe, Japan), K. Hirata (Kobe, Japan)
| |
Predictors of perioperative morbidity and mortality in patients with Antiphospholipid antibody syndrome (APS) and chronic thromboembolic pulmonary hypertension (CTPEH) after Endarterectomy Pulmonary.
E. Bermudez (CDMX, Mexico), R. Zebadua (CDMX, Mexico), J. Lopez (CDMX, Mexico), M. Pozas (CDMX, Mexico), L. Zorrilla (CDMX, Mexico), T. Pulido (CDMX, Mexico), J. Sandoval (CDMX, Mexico), N. Zayas (CDMX, Mexico)
| |